Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
ADC Therapeutics’s $60 Million Common Shares Secondary Offering
Precigen’s $75 Million Common Stock Offering
Davis Polk and Hogan Lovells advised Precigen on the offering, and Goodwin Procter advised the underwriters involved. Precigen Inc. announced the SEC-registered offering of an aggregate of...
Terns Pharmaceuticals’ $86 Million Common Stock Offering
Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Brookdale Senior Living’s $125 Million Tangible Equity Units Offering
Davis Polk advised the representatives of the underwriters in the offering. Brookdale Senior Living Inc. executed a $125 million SEC-registered offering of 2,500,000 tangible equity units. BofA...
Ormat Technologies’ $338 Million Common Stock Offering
White & Case advised Ormat Technologies, Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Kirkland advised ORIX Corporation....
NextGen Healthcare’s $230 Million Convertible Senior Notes Offering
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....
XPO Logistics’ $418 Million Cash Tender Offer
Wachtell, Lipton, Rosen & Katz advised XPO, while Davis Polk advised the dealer managers on the deal. XPO Logistics, Inc. announced the expiration, results and settlement...
Immatics’ $110 Million Shares Offering
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
Solid Biosciences’ $75 Million Common Stock PIPE Offering
Davis Polk advised the placement agent, BofA Securities, Inc., in the offering. Solid Biosciences, Inc. executed its private placement of $75 million of common stock. The financing is...
Alignment Healthcare’s $131.5 Million Secondary Offering
Paul, Weiss advised Alignment Healthcare, while Davis Polk advised the underwriter, J.P. Morgan Securities LLC, in the offering. Alignment Healthcare executed its SEC-registered secondary offering of 9,000,000...
Immunocore’s $250 Million At-The-Market Offering
Davis Polk advised Jefferies, the sales agent, in the offering. Immunocore Holdings plc announced the SEC-registered at-the-marketing offering program of its American depositary shares (ADSs) representing its ordinary...
Assertio’s $70 Million Convertible Senior Notes Offering
Davis Polk advised SVB Securities LLC, the sole initial purchaser, in the offering. Assertio Holdings, Inc. executed the offering of $70 million aggregate principal amount of...